Skip to main content

Ablagerungsdermatosen, Hautveränderungen bei Stoffwechselstörungen und Mangelsyndromen

  • Chapter
Therapie der Hautkrankheiten

Zusammenfassung

Gicht ist auf eine heterogene Störung des Purinstoffwechsels zurückzuführen und manifestiert sich durch Hyperurikämie im Serum sowie durch Ablagerung von Uratkristallen im Gelenkbereich bzw unter der Haut. Vor allem Männer ab dem 40. Lebensjahr sind betroffen. Im Verlauf treten rezidivierend akute Gichtanfälle, vorzugsweise in den Gelenken der distalen Extremitäten (Podagra) auf. Bei chronischem Verlauf kommt es zu destruierenden Gelenkveränderungen, Nephrolithiasis und anderen Nephropathien. An der Haut kommt es vorzugsweise im Bereich der äußeren Helix der Ohren sowie an den Finger- und Zehengelenken zur Entstehung von Gichttophi infolge von Uratkristallablagerungen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Alloway JA, Moriarty MJ, Hoogland YT, Nashel DJ (1993) Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis. J Rheumatol 20: 111–113

    PubMed  CAS  Google Scholar 

  • Axelrod D, Preston S (1988) Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout. Arthritis Rheum 31: 803–805

    PubMed  CAS  Google Scholar 

  • Baethge BA, Work J, Landreneau MD, McDonald JC (1993) Tophaceous gout in patients with renal transplants treated with cyclosporine A. J Rheumatol 20: 718–720

    PubMed  CAS  Google Scholar 

  • Blume U, Zouboulis CC, Pineda-Fernandez MS (1993) New indications in cryosurgery. Dermatol Monatsschr 179: 265–269

    Google Scholar 

  • Boyd RE (1993) Gout: modern management of an ancient malady. J S C Med Assoc 89: 240–243

    PubMed  CAS  Google Scholar 

  • Braun-Falco O, Korting HC, Zieniche H et al. (1988) Eruptive Histiozytome and Xanthoma disseminatum als Manifestationsformen derselben Erkrankung? Hautarzt 39: 652–657

    PubMed  CAS  Google Scholar 

  • Caputo R, Monti M, Berti E et al. (1986) Normolipemic eruptive cutaneous xanthomatosis. Arch Dermatol 122: 1294–1297

    PubMed  CAS  Google Scholar 

  • Caputo R, Grimait R, Gelmetti C, Cottoni F (1993) Unusual aspects of juvenile xanthogranuloma. J Am Acad Dermatol 29: 868–870

    PubMed  CAS  Google Scholar 

  • Cohen BA, Hood A (1989) Xanthogranuloma: report on clinical and histologic findings in 64 patients. Pediatr Dermatol 6: 262–266

    PubMed  CAS  Google Scholar 

  • Cruz PD, East C, Bergstresser MD (1988) Dermal, subcutaneous and tendon xanthomas. Diagnostic markers for specific lipoprotein disorders. J Am Acad Dermatol 19: 95–111

    PubMed  Google Scholar 

  • Gianotti F, Caputo R (1985) Histiocytic syndromes: a review. J Am Acad Dermatol 13: 383–404

    PubMed  CAS  Google Scholar 

  • Goldstein GD (1984) The Köbner phenomenon with eruptive xanthomas. J Am Acad Dermatol 10: 1064–1065

    PubMed  CAS  Google Scholar 

  • Groff GD, Franck WA, Raddatz DA (1990) Systemic steroid therapy for acute gout: A clinical trial and review of the literature. Semin Arthritis Rheum 19: 329–336

    PubMed  CAS  Google Scholar 

  • Hambrecht R, v Hodenberg E, Schuler G et al. (1991) Typ-III-Hyperlipoproteinämie bei monoklonaler IgM-Gammopathie. DMW 116: 1710–1714

    CAS  Google Scholar 

  • Illingworth DR (1988) Drug therapy of hypercholesterolemia. Clin Chem 34: B 123–132

    Google Scholar 

  • Illingworth DR, Bacon SP, Larsen KK (1988) Longterm experience with HMG-CoA reductase inhibitors in the therapy of hypercholesterolemia. Atheroscl Rev 8: 161–187

    Google Scholar 

  • Odell WD, Doggett RS (1993) Xanthoma disseminatum, a rare cause of diabetes insipidus. J Clin Endocrinol Metab 76: 777–780

    PubMed  CAS  Google Scholar 

  • Parker F (1985) Xanthomas and hyperlipidemias. J Am Acad Dermatol 13: 1–30

    PubMed  CAS  Google Scholar 

  • Resnick SD, Woosley J, Azizkhan RG (1990) Giant juvenile xanthogranuloma: exophytic and endophytic variants. Pediatr Dermatol 7: 185–188

    PubMed  CAS  Google Scholar 

  • Ringel E, Moschella S (1985) Primary histiocytic dermatoses. Arch Dermatol 121: 1531–1541

    PubMed  CAS  Google Scholar 

  • Roederer G, Xhignesse M, Davignon J (1988) Eruptive and tubero-eruptive xanthomas of the skin arising on sites of prior injury. JAMA 260: 1282–1283

    PubMed  CAS  Google Scholar 

  • Star VL, Hochberg MC (1993) Prevention and management of gout. Drugs 45: 212–222

    PubMed  CAS  Google Scholar 

  • Thompson GR (1989) Drug treatment of hyperlipidaemia. In: Handbook of hyperlipidaemia. Current Science London, p 187

    Google Scholar 

  • Varotti C, Bettoli V, Berti E et al. (1991) Xanthoma disseminatum: A case with extensive mucous membrane involvement. J Am Acad Dermatol 25: 433–436

    PubMed  CAS  Google Scholar 

  • Vinson RP, Harrington AC (1991) Clinical significance and treatment of xanthomas. Am Fam Physician 44: 1206–1210

    PubMed  CAS  Google Scholar 

  • Winkelmann RK (1981) Cutaneous syndromes of non-X histiocytosis: a review of the macrophage-histiocyte diseases of the skin. Arch Dermatol 117: 667–672

    PubMed  CAS  Google Scholar 

  • Breathnach SM (1988) Amyloid and amyloidosis. J Am Acad Dermatol 18: 1–16

    PubMed  CAS  Google Scholar 

  • Helander I, Hopsu-Havu VK (1986) Treatment of lichen amyloidosus by etretinate. Clin Exp Dermatol 11: 574–577

    PubMed  CAS  Google Scholar 

  • Marschalko M, Daroczy J, Soos G (1988) Etretinate for the treatment of Lichen amyloidosus. Arch Dermatol 124: 657–659

    PubMed  CAS  Google Scholar 

  • Monfrecola G, Iandoli R, Bruno G, Martellotta D (1985) Lichen amyloidosus: a new approach. Acta Derm Venereol (Stockh) 65: 453–455

    CAS  Google Scholar 

  • Ollague W (1987) Primary cutaneous amyloidosis. J Int Dermatol 26: 135

    CAS  Google Scholar 

  • Pasricha JS, Seetharam KA (1987) Low dose cyclophosphamide therapy in lichen amyloidosus. Indian J Dermatol Venereol Leprol 53: 273–274

    Google Scholar 

  • Pravata G, Pinto G, Bosco M et al. (1989) Unusual localisation of Lichen amyloidosus. Topical treatment with dimethylsulfoxide. Acta Derm Venereol (Stockh) 69: 259–260

    CAS  Google Scholar 

  • Wong CK, Li WM (1982) Dermabrasion for lichen amyloidosus. Report of a long-term study. Arch Dermatol 118: 302–304

    PubMed  CAS  Google Scholar 

  • Cockerell CJ, Dolan ET (1992) Widespread cutaneous and systemic calcification (calciphylaxis) in patients with acquired immunodeficiency syndrome and renal disease. J Am Acad Dermatol 26: 559–562

    PubMed  CAS  Google Scholar 

  • Cribier B, Grosshans E (1992) Calcinoses cutanées. Ann Dermatol Venereol 119: 151–168

    PubMed  CAS  Google Scholar 

  • Grosshans E, Cribier B (1990) Kalzinosen der Haut. Hautarzt 41 [Suppl 10]: 60–65

    Google Scholar 

  • Khafif RA, DeLima C, Silverberg A et al. (1990) Calciphylaxis and systemic calcinosis. Arch Intern Med 50: 956–959

    Google Scholar 

  • Mehregan AH (1984) Calcinosis cutis: a review of the clinical forms and report of 75 cases. Semin Dermatol 3: 53–61

    Google Scholar 

  • Mehregan DA, Winkelmann RK (1989) Cutaneous gangrene, vascular calcification, and hyperparathyroidism. Mayo Clin Proc 64: 211–215

    PubMed  CAS  Google Scholar 

  • Miller JA, Machin SJ, Dowd PD (1988) Cutaneous gangrene with hyperparathyroidism. Clin Exp Dermatol 13: 204–206

    PubMed  CAS  Google Scholar 

  • Nassim JR, Connolly CK (1970) Treatment of calcinosis universalis with aluminium hydroxide. Arch Dis Child 45: 118–121

    PubMed  CAS  Google Scholar 

  • Pitt AE, Ethington JE, Troy JL (1990) Self-healing dystrophic calcinosis following trauma with transepidermal elimination Cutis 45: 28–30

    PubMed  CAS  Google Scholar 

  • Schuhmachers G, Worret W-I (1992) Osteoma cutis. Pathogenese und therapeutische Möglichkeiten. Hautarzt 43: 422–425

    PubMed  CAS  Google Scholar 

  • Wang WJ, Lo WL, Wong CK (1988) Calcinosis cutis in juvenile dermatomyositis: remarkable response to aluminium hydroxide therapy. Arch Dermatol 124: 1721–1722

    PubMed  CAS  Google Scholar 

  • Welk RA, Alix DR (1987) A community hospital experience with total parathyroidectomy and autotransplantation for renal hyperparathyroidism. Am Surgeon 53: 622–627

    PubMed  CAS  Google Scholar 

  • Wright S, Naysaria H, Leigh IM (1991) Idiopathic scrotal calcinosis is idiopathic. J Am Acad Dermatol 24: 727–730

    PubMed  CAS  Google Scholar 

  • Zimmermann J, Hartschuh W, Petzoldt D (1990) Tumorartige Kalzinose. Hautarzt 41: 375–377

    PubMed  CAS  Google Scholar 

  • Zouboulis CC, Weihe J, Gollnick H et al. (1990) Calcinosis cutis: kutane Manifestationen generalisierter Kalzinose bei renalem Hyperparathyreoidismus. Hautarzt 41: 212–217

    PubMed  CAS  Google Scholar 

  • Dowlati A, Dowlati Y, Mansauri P et al. (1989) Lipoid proteinosis and its response to etretinate therapy. In: Pierard GE, Pierard-Franchimont C (eds) The der-mis: from biology to diseases. Monographies Dermatopathologiques Liegoises, Paris, pp 135–142

    Google Scholar 

  • Fleischmajer R, Krieg T, Dziadek M et al. (1984) Ultra-structure and composition of connective tissue in hyalinosis cutis et mucosae. J Invest Dermatol 82: 252–258

    PubMed  CAS  Google Scholar 

  • Haußner I, Biltz S, Rauterberg E et al. (1991) Hyalinosis cutis et mucosae ( Morbus Urbach-Wiethe) — ultrastrukturelle und immunologische Merkmale. Hautarzt 42: 28–33

    Google Scholar 

  • Helm D von der, Ring J, Schmoeckel C, Braun Falco O (1989) Erworbene Hyalinosis cutis et mucosae bei Plasmozytom mit monoklonaler IgG-lambda-Gammopathie. Hautarzt 40: 153–157

    PubMed  Google Scholar 

  • Knorr HL, Meythaler HF, Naumann GO (1991) Epiphora als Leitsymptom des Urbach-Wiethe-Syndroms bei einem Geschwisterpaar. Fortschr Ophthalmo 188: 168–172

    Google Scholar 

  • Olsen DR, Chu ML, Uitto J (1988) Expression of basement membrane zone genes coding for type IV pro-collagen and laminin by human skin fibroblasts in vitro: elevated al(IV) collagen mRNA levels in lipoid proteinosis. J Invest Dermatol 90: 734–738

    PubMed  CAS  Google Scholar 

  • Simon M Jr, Zobe A, Fartasch M (1990) Hyalinosis cutis et mucosae ( Urbach-Wiethe) bei einem Geschwisterpaar. Hautarzt 41: 458–460

    PubMed  Google Scholar 

  • Wong CK, Lin CS (1988) Remarkable response of lipoid proteinosis to oral dimethyl sulphoxide. Br J Dermatol 119: 541–544

    PubMed  CAS  Google Scholar 

  • Cohen PR, Rabinowicz AD, Ruskowski AM, Deleo VA (1990) Reticular erythematous mucinosis syndrome: a review of the world literature and report in a prepubertal child. Pediatr Dermatol 7: 1–10

    PubMed  CAS  Google Scholar 

  • McFadden N, Larsen TE (1988) Reticular erythema-tous mucinosis and photosensitivity: a case study. Photodermatol 5: 270–272

    PubMed  CAS  Google Scholar 

  • Steigleder GK, Kanzow G (1980) Muzinablagerungen in der Dermis und REM-Syndrom. Hautarzt 31: 575–583

    PubMed  CAS  Google Scholar 

  • Aberer W, Wolff K (1988) Skleromyxödem: immunsuppressive Therapie mit Zyklophosphamid. Hautarzt 39: 277–280

    PubMed  CAS  Google Scholar 

  • Bastenie PA, Bonnyns M, Vanhaelst L (1985) Natural history of primary myxedema. Am J Med 79: 91–100

    PubMed  CAS  Google Scholar 

  • Benoit FL, Greenspan FS (1967) Corticoid therapy for pretibial myxedema: Obervations on the long-acting thyroid stimulator. Ann Intern Med 66: 711–720

    PubMed  CAS  Google Scholar 

  • Berkson M, Lazarus GS, Uberti-Benz M, Rook AH (1992) Extracorporal photochemotherapy: a potentially useful treatment for scleromyxedema. J Am Acad Dermatol 26: 724

    Google Scholar 

  • Bleehen SS, Slater DN, Mahood J, Church RE (1982) Reticular erythematous mucinosis: light and electron microscopy, immunofluorescence and histochemical findings. Br J Dermatol 106: 9–18

    PubMed  CAS  Google Scholar 

  • Blume-Peytavi U, Zouboulis CC, Jacobi H et al. (1994) Successful outcome of cryosurgery in patients with granuloma annulare. Br J Dermatol 130: 494 197

    Google Scholar 

  • Bonnetblanc JM, Bedane C (1991) Regression of scleromyxedema with topical betamethasone and dimethyl sulfoxide. A 30-month follow-up. Arch Dermatol 127: 1733–1734

    PubMed  CAS  Google Scholar 

  • Braddock SW, Davis CS, Davis RB (1988) Reticular erythematous mucinosis and thrombocytopenic purpura. Report of a case and review of the world literature, including plaquelike cutaneous mucinosis. J Am Acad Dermatol 19: 859–868

    PubMed  CAS  Google Scholar 

  • Braddock SW, Kay HD, Maennle D et al. (1993) Clinical and immunologic studies in reticular erythema-tous mucinosis and Jessner’s lymphocytic infiltrate of skin. J Am Acad Dermatol 28: 691–695

    PubMed  CAS  Google Scholar 

  • Brenner S, Yust I (1984) Treatment of scleromyxedema with etretinate. J Am Acad Dermatol 10: 295–296

    PubMed  CAS  Google Scholar 

  • Bulengo Ransby SM, Ellis CN, Griffiths CE et al. (1992) Failure of reticular erythematous mucinosis to respond to cyclosporine. J Am Acad Dermatol 27: 825–828

    PubMed  CAS  Google Scholar 

  • Bull RH, Coburn PR, Mortimer PS (1993) Pretibial myxoedema: a manifestation of lymphoedema? Lancet 341: 403–404

    PubMed  CAS  Google Scholar 

  • Chang CC, Chang TC, Kao SC et al. (1993) Pentoxifylline inhibits the proliferation and glycosaminoglycan synthesis of cultured fibroblasts derived from patients with Graves’ ophthalmopathy and pretibial myxoedema. Acta Endocrinol (Copenh) 129: 322–327

    CAS  Google Scholar 

  • Cohen PR, Rabinowitz AD, Ruszkowski AM, DeLeo VA (1990) Reticular erythematous mucinosis syndrome: review of the world literature and report of the syndrome in a prepubertal child. Pediatr Dermatol 7: 1–10

    PubMed  CAS  Google Scholar 

  • Dabski K, Winkelmann RK (1989) Generalized granuloma annulare: clinical and laboratory findings in 100 patients. J Am Acad Dermatol 20: 39–47

    PubMed  CAS  Google Scholar 

  • Dandona P, Marschall NJ, Bidey SP et al. (1979) Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis. Br Med J 1: 374–376

    PubMed  CAS  Google Scholar 

  • Farr PM, Ive FA (1984) PUVA treatment of scleromyxoedema. Br J Dermatol 110: 347–350

    PubMed  CAS  Google Scholar 

  • Fatourechi V, Garrity JA, Bartley GB et al. (1993) Orbital decompression in Graves’ ophthalmopathy associated with pretibial myxedema. J Endocrinol Invest 16: 433–437

    PubMed  CAS  Google Scholar 

  • Gibson LE, Muller SA, Leiferman KM, Peters MS (1989) Follicular mucinosis: clinical and histopathologic study. J Am Acad Dermatol 20: 441–446

    PubMed  CAS  Google Scholar 

  • Göring HD, Ziemer A (1989) Immunpathogenetische, endokrinologische und therapeutische Probleme des EMO-Syndroms. Betrachtungen anhand einer Krankenbeobachtung. Dermatol Monatsschr 175: 492–498

    PubMed  Google Scholar 

  • Hagedorn M, Slanina J, Kuphal K, Wenning J (1986) Behandlung einer symptomatischen Mucinosis follicularis bei Mycosis fungoides mit schnellen Elektronen. Hautarzt 37: 667–672

    PubMed  CAS  Google Scholar 

  • Harris RB, Perry HO, Kyle RA et al. (1979) Treatment of scleromyxedema with melphalan. Arch Dermatol 115: 295–299

    PubMed  CAS  Google Scholar 

  • Heymann WR (1992) Cutaneous manifestations of thyroid disease. J Am Acad Dermatol 26: 885–902

    PubMed  CAS  Google Scholar 

  • Hisler BM, Savoy LB, Hashimoto K (1991) Improvement of scleromyxedema associated with isotretinoin therapy. J Am Acad Dermatol 24: 854–857

    PubMed  CAS  Google Scholar 

  • Hornstein OP (1984) Schilddrüse, Nebenschilddrüse und Haut. Z Hautkr 59: 1125–1126, 1129–1132, 1137–1143

    Google Scholar 

  • Horster FA, Wildmeister W (1983) Endokrine Orbitopathie. Therapieerfolge bei 148 Patienten unter Berücksichtigung neuer pathogenetischer Aspekte. Dtsch Med Wochenschr 108: 413–415

    PubMed  CAS  Google Scholar 

  • Howsden SM, Herndon JH, Freeman RG (1975) Lichen myxedematosus: A dermal infiltrative disorder responsive to cyclophosphamide therapy. Arch Dermatol 111: 1325–1330

    PubMed  CAS  Google Scholar 

  • Ingber A, Sandbank M (1988) Retikuläre erythematöse Muzinose ( REM ). Z Hautkr 63: 986–998

    PubMed  CAS  Google Scholar 

  • Kaufman D, Truhan AP, Roenigk HH Jr (1987) Scleromyxedema: systemic manifestations and cosmetic improvement from dermabrasion. Cutis 39: 321–324

    PubMed  CAS  Google Scholar 

  • Kaymen AH, Nasr A, Grekin RC (1989) The use of carbon dioxide laser in lichen myxedematosus. J Dermatol Surg Oncol 15: 862–865

    PubMed  CAS  Google Scholar 

  • Kenicer KJA, Lakshmipathi T (1982) Follicular mucinosis treated with PUVA. Br J Dermatol 107 [Suppl 22]: 48–49

    Google Scholar 

  • Kodama H, Umemura S, Nohara N (1988) Follicular mucinosis: response to indomethacin. J Dermatol 15: 72–75

    PubMed  CAS  Google Scholar 

  • Kohn LD, Alvarez F, Marcocci C et al. (1986) Monoclonal antibody studies defining the origin and properties of autoantibodies in Graves’ disease. Ann N Y Acad Sci 475: 157–173

    PubMed  CAS  Google Scholar 

  • Konishi J, Iida Y, Kasagi K et al. (1985) Primary myxedema with thyrotrophin-binding inhibitor immunoglobulins. Clinical and laboratory findings in 15 patients. Ann Intern Med 103: 26–31

    PubMed  CAS  Google Scholar 

  • Koshiyama H, Mori S, Fujiwara K et al. (1993) Successful treatment of hypothyroid Graves’ disease with a combination of levothyroxine replacement, intravenous high-dose steroid and irradiation to the orbit. Intern Med 32: 421–423

    PubMed  CAS  Google Scholar 

  • Kriss JP (1987) Pathogenesis and treatment of pretibial myxedema. Endocrinol Metab Clin North Am 16: 409–415

    PubMed  CAS  Google Scholar 

  • Kucer KA, Luscombe HA, Kauh YC (1980) Pretibial myxedema: Recurrence after skin grafting. Arch Dermatol 116: 1076–1077

    PubMed  CAS  Google Scholar 

  • Lacour JP, Castanet J, Perrin C, Ortonne JP (1993) Follicular mycosis fungoides. A clinical and histologic variant of cutaneous T-cell lymphoma: report of two cases. J Am Acad Dermatol 29: 330–334

    PubMed  CAS  Google Scholar 

  • Lang PG (1981) Thyroid disorders. In: Callen JP (ed) Cutaneous aspects of internal disease. Year Book Medical Publishers, London, pp 437–450

    Google Scholar 

  • Lang PG, Sisson JC, Lynch PJ (1975) Intralesional triamcinolone therapy for pretibial myxedema. Arch Dermtol 111: 197–202

    CAS  Google Scholar 

  • Lewis RA, Slater N, Croft DN (1979) Exophthalmos and pretibial myxoedema not responding to plasma phoresis. Br Med J 1: 390–391

    Google Scholar 

  • Lominska Lasota K, Rosen Uzelac G, Reichl W, Bauer R (1988) Skleromyxödem-Therapie mit Isotretinoin. Z Hautkr 63: 137–8, 141

    Google Scholar 

  • Lund P, Horsley Petersen K, Helin P, Parving HH (1986) The effect of 1-thyroxine treatment on skin accumulation of acid glycosaminoglycans in primary myxoedema. Acta Endocrinol (Copenh) 113: 56–58

    CAS  Google Scholar 

  • Macfarlane AW, Davenport A, Verbov JL, Goldsmith HJ (1987) Scleromyxoedema–successful treatment with plasma exchange and immunosuppression. Br J Dermatol 117: 653–657

    PubMed  CAS  Google Scholar 

  • Matsuoka LY, Wortsman J, Carlisle KS et al. (1984) The acquired cutaneous mucinoses. Arch Intern Med 144: 1974–1980

    PubMed  CAS  Google Scholar 

  • McLaughlin H, Hobbs JR (1973) Clinical significance of Bence-Jones-proteinuria. Prot Biol Fl 20: 251–254

    Google Scholar 

  • Meissner K, Weyer U, Kowalzick L, Altenhoff J (1991) Successful treatment of primary progressive follicular mucinosis with interferons. J Am Acad Dermatol 24: 848–850

    PubMed  CAS  Google Scholar 

  • Milam CP, Cohen LE, Fenske NA, Ling NS (1988) Scleromyxedema: therapeutic response to isotretinoin in three patients. J Am Acad Dermatol 19: 469–477

    PubMed  CAS  Google Scholar 

  • Montgomery H, Underwood L (1953) Lichen myxedematosus (differentiation from cutaneous myxedemas or mucoid states). J Invest Dermatol 20: 213–236

    PubMed  CAS  Google Scholar 

  • Nickoloff BJ, Wood C (1985) Benign idiopathic versus mycosis fungoides-associated follicular mucinosis. Pediatr Dermatol 2: 201–206

    PubMed  CAS  Google Scholar 

  • Noppen M, Velkeniers B, Steenssens L, Vanhaelst L (1988) Beneficial effects of plasmapheresis followed by immunosuppressive therapy in pretibial myxedema. Acta Clin Belg 43: 381–383

    PubMed  CAS  Google Scholar 

  • Parker LN, Wu S-Y, Lai MK et al. (1982) The early diagnosis of atypical thyroid acropathy. Arch Intern Med 142: 1749–1751

    PubMed  CAS  Google Scholar 

  • Penmetcha M, Highet AS, Hopkinson JM (1987) Failure of PUVA in lichen myxoedematosus: acceleration of associated multiple keratoacanthomas with development of squamous carcinoma. Clin Exp Dermatol 12: 220–223

    PubMed  CAS  Google Scholar 

  • Picascia DD, Magid ML, Minkin RB (1989) Pruritic papular eruption. Papular mucinosis (lichen myxedematosus). Arch Dermatol 125: 986–990

    PubMed  CAS  Google Scholar 

  • Reynolds NJ, Collins CMP, Burton JL (1992) Discrete papular mucinosis responding to intralesional and topical steroids. Arch Dermatol 128: 857–858

    PubMed  CAS  Google Scholar 

  • Rongioletti F, Rebora A (1991) The new cutaneous mucinoses: a review with an up-to-date classification of cutaneous mucinoses. J Am Acad Dermatol 24: 265–270

    PubMed  CAS  Google Scholar 

  • Rongioletti F, Rebora A (1993) Les mucinoses cutanées. Ann Dermatol Venereol 120: 75–87

    PubMed  CAS  Google Scholar 

  • Rustin MHA, Bunker CB, Levene GM (1989) Follicular mucinosis presenting as acute dermatitis and response to dapsone. Clin Exp Dermato 114: 382–384

    Google Scholar 

  • Shishiba Y, Imai Y, Odajima R et al. (1992) Immunoglobulin G of patients with circumscribed pretibial myxedema of Graves’ disease stimulates proteoglycan synthesis in human skin fibroblasts in culture. Acta Endocrinol Copenh 127: 44–51

    PubMed  CAS  Google Scholar 

  • Steigleder GK, Kanzow G (1980) Muzinablagerungen in der Dennis and REM-Syndrom. Hautarzt 31: 575–583

    PubMed  CAS  Google Scholar 

  • Steigleder GK, Küchmeister B (1985) Cutaneous mucinous deposits. J Cut Pathol 12: 334–347

    CAS  Google Scholar 

  • Steigleder GK, Schultze H-J (1990) Schleimablagerungen (M) in der Haut, ein Autoimmunphänomen? Hautarzt 41 [Suppl 10]: 66–70

    Google Scholar 

  • Steigleder GK, Gartman H, Linker U (1974) REM syndrome: Reticular Erythematous mucinosis (round-cell erythematosis), a new entity? Br J Dermatol 91: 191–199

    PubMed  CAS  Google Scholar 

  • Stephens CJ, McKee PH, Black MM (1993) The dermal mucinoses. Adv Dermatol 8: 201–227

    PubMed  CAS  Google Scholar 

  • Stewart M, Smoller BR (1991) Follicular mucinosis in Hodgkin’s disease: a poor prognostic sign? J Am Acad Dermatol 24: 784–785

    PubMed  CAS  Google Scholar 

  • Tosti A, Fanti PA, Peserico A, Varotti C (1992) Linear alopecia mucinosa along Blaschko lines. Acta Dermatol Venereol (Stockh) 72: 155–156

    CAS  Google Scholar 

  • Trüeb R, Bruckner-Tuderman L (1990) Generalisierte Mucinosis follicularis idiopathica. Hautarzt 41: 625–627

    PubMed  Google Scholar 

  • Truhan AP, Roenigk HH Jr (1986) The cutaneous mucinoses. J Am Acad Dermatol 14: 1–18

    PubMed  CAS  Google Scholar 

  • Varga E, Kiss A, Schneider I (1986) Skleromyxödem. Z Hautkr 61: 439–442

    PubMed  CAS  Google Scholar 

  • Volden G (1992) Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing. Acta Derm Venereol (Stockh) 72: 69–71

    CAS  Google Scholar 

  • Wieder JM, Barton KL, Baron JM, Soltani K (1993) Lichen myxedematosus treated with chlorambucil. J Dermatol Surg Oncol 19: 475–476

    PubMed  CAS  Google Scholar 

  • Yaron M, Yaron I, Yust I, Brenner S (1985) Lichen myxedematosus (scleromyxedema) serum stimulates hyaluronic acid and prostaglandin E production by human fibroblasts. J Rheumatol 12: 171–175

    CAS  Google Scholar 

  • Barnes PM, Moynahan EJ (1973) Zinc deficiency in acrodermatitis enteropathica: multiple dietary intolerance treated with synthetic diet. Proc Roy Soc Med 66: 327–329

    PubMed  CAS  Google Scholar 

  • Bilinski DL, Ehrenkranz RA, Cooley-Jacobs J, Mc Guire J (1987) Symptomatic zinc deficiency in a breast-fed, premature infant. Arch Dermatol 123: 1221–1224

    PubMed  CAS  Google Scholar 

  • Cutler EA, Palmer J, Kontras SB (1977) Chemotherapy and possible zinc deficiency. New Engl J Med 297: 168

    PubMed  CAS  Google Scholar 

  • Kanekura T, Tashiro M (1991) Zinc deficiency: report of three cases. Cutis 48: 161–164

    PubMed  CAS  Google Scholar 

  • Michaelsson G (1974) Zinc therapy in acrodermatitis enteropathica. Acta Derm Venereol (Stockh) 54: 377–381

    CAS  Google Scholar 

  • Reichel M, Mauro TM, Ziboh VA, Huntley AC (1992) Acrodermatitis enteropathica in a patient with the acquired immunodeficiency syndrome. Arch Dermatol 128: 415–416

    PubMed  CAS  Google Scholar 

  • Shils ME, Burke AW, Greene HI et al. (1979) Guidelines for essential trace element preparations for parenteral use. A statement by an expert panel. J Am Acad Dermatol 241: 2051–2054

    CAS  Google Scholar 

  • Walldius G, Michaelsson G, Hardell LI, Aberg H (1983) The effects of diet and zinc treatment on the fatty acid composition of serum lipids and adipose tissue and on serum lipoproteins in two adolescent patients with acrodermatitis enteropathica. Am J Clin Nutr 38: 512–522

    PubMed  CAS  Google Scholar 

  • Hendricks WM (1991) Pellagra and pellagralike dermatoses: etiology, differential diagnosis, dermatopathology, and treatment. Semin Dermatol 10: 282–292

    PubMed  CAS  Google Scholar 

  • Rapaport MJ (1985) Pellagra in a patient with anorexia nervosa. Arch Dermatol 121: 255–257

    PubMed  CAS  Google Scholar 

  • Stratigos JD, Katsambas A (1977) Pellagra: a still existing disease. Br J Dermatol 96: 99–106

    PubMed  CAS  Google Scholar 

  • Collins FS, Dummer GK, Schwartz RP et al. (1980) Neonatal arginosuccinic aciduria — survival after early diagnosis and dietary management. J Pediatr 96: 429–431

    PubMed  CAS  Google Scholar 

  • Goldsmith LA, Thorpe J, Roe CR (1979) Hepatic enzymes of tyrosine metabolism in tyrosinaemia II. J Invest Dermatol 73: 530–532

    PubMed  CAS  Google Scholar 

  • Hanhart E (1947) Neue Sonderformen von Keratosis palmoplantaris. Dermatologica 94: 286–308

    PubMed  CAS  Google Scholar 

  • Hill A, Nordin PM, Zaleski WA (1970) Dietary treat- ment of tyrosinosis. J Am Diet Assoc 56: 308–312

    PubMed  CAS  Google Scholar 

  • Scriver CR (1989) The hyperphenylalaninaemias. In: Scriver CR et al. (eds) Metabolic basis of inherited disease 6th edn. McGraw-Hill, New York

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Orfanos, C.E., Garbe, C. (1995). Ablagerungsdermatosen, Hautveränderungen bei Stoffwechselstörungen und Mangelsyndromen. In: Therapie der Hautkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97602-5_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-97602-5_31

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-97603-2

  • Online ISBN: 978-3-642-97602-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics